Sanofi lifts 2026 sales outlook to about 10% growth at constant currencies

PUBT · 4d ago
Sanofi lifts 2026 sales outlook to about 10% growth at constant currencies
  • Sanofi raised its 2026 outlook, targeting revenue growth of about 10% at constant exchange rates.
  • It expects business EPS growth at constant exchange rates to run slightly above sales growth.
  • The upgrade follows Q2 revenue of EUR 11.6 billion, up 17.8% at constant exchange rates.
  • Q2 business EPS was EUR 2.09, up 33.3% at constant exchange rates.
  • July 2026 FX assumptions imply about a 1% revenue headwind, about a 2% headwind to business EPS.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sanofi SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607300130OMX_____CNEWS_FR_GNW1001255118_fr) on July 30, 2026, and is solely responsible for the information contained therein.